Eikon Therapeutics Inc (EIKN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 87,337 | 0 | 71,383 | 0 |
| Operating Income | -87,337 | N/A | -71,383 | N/A |
| Other Income | 4,379 | 0 | 3,140 | 0 |
| Pre-tax Income | -82,958 | 0 | -68,243 | 0 |
| Net Income Continuous | -82,958 | N/A | -68,243 | N/A |
| Net Income | $-82,958 | $N/A | $-68,243 | $N/A |
| EPS Basic Total Ops | -2.46 | N/A | -26.91 | N/A |
| EPS Basic Continuous Ops | -2.46 | N/A | -24.63 | N/A |
| EPS Diluted Total Ops | -2.46 | N/A | -26.91 | N/A |
| EPS Diluted Continuous Ops | -2.46 | N/A | -24.63 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.46 | N/A | N/A | N/A |
| EBITDA(a) | $-82,224 | $N/A | $-64,917 | $N/A |